I would suggest that it has been moderately well (dis)proven that HDL is a marker for risk, not a treatment target for risk. E.g. the CTEP trials and the Mendelian Randomization data both indicate this.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.